Expert commentary: The HARMONY trial
John Wilding discusses the unexpected results of HARMONY, the albiglutide cardiovascular outcomes study (2:43).
John Wilding discusses the unexpected results of HARMONY, the albiglutide cardiovascular outcomes study (2:43).
Primary findings, 2-year outcomes and translating this landmark trial into practice
Version: 0.1251.0